Nicotinamide Riboside
Nicotinamide Riboside is a dietary supplement with 49 clinical trials. Currently 21 active trials ongoing. Historical success rate of 87.5%.
Success Metrics
Based on 21 completed trials
Phase Distribution
Phase Distribution
9
Early Stage
18
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
84.0%
21 of 25 finished
16.0%
4 ended early
21
trials recruiting
49
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Impacts of Nicotinamide Riboside on Functional Capacity and Muscle Physiology in Older Veterans
Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic Rate
The Effect of NAD Supplementation on Brain Vascular Health in Aging
Effects of Nicotinamide Riboside on Bioenergetics and Oxidative Stress in Mild Cognitive Impairment/Alzheimer's Dementia
Nicotinamide Riboside Oral Supplementation in Macula Off Retinal Detachment
Clinical Trials (49)
Impacts of Nicotinamide Riboside on Functional Capacity and Muscle Physiology in Older Veterans
Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic Rate
The Effect of NAD Supplementation on Brain Vascular Health in Aging
Effects of Nicotinamide Riboside on Bioenergetics and Oxidative Stress in Mild Cognitive Impairment/Alzheimer's Dementia
Nicotinamide Riboside Oral Supplementation in Macula Off Retinal Detachment
NAD Supplementation and Vascular Health in PAD
NAD+ and Exercise in FA
Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus
A Study to Evaluate Vitamin B3 Derivative to Treat Mitochondrial Myopathy
Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
The Effect of Exercise and Nicotinamide Riboside Muscle Health and Insulin Resistance in Survivors of Childhood Cancer
Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis
A Randomized Controlled Trial of Nicotinamide Riboside Supplementation in Early Parkinson's Disease
Benefits of Nicotinamide Riboside Upon Cognition and Sleep
NIAGEN and Persistent Chemotherapy-Induced Peripheral Neuropathy
Nicotinamide Riboside Clinical Trial for GWI
ACEs, SIRT1, and Premature Vascular Aging in Humans
N-DOSE: A Dose Optimization Trial of Nicotinamide Riboside in Parkinson's Disease
Comparisons of NAD Precursors for Neuroenhancement in Glaucoma Patients
NOPARK Open Label Extension Study
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 49